NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Xenoma Inc.

Xenoma Inc.

Private
TokyoHealthcare & Life Scienceshttps://xenoma.com/

Last Round

Corporate Funding

Aug 10, 2022

Total Funding Raised

$3.46M

Company Overview

Xenoma Inc. is a clothing and healthcare company that develops, manufactures, and sells 'e-skin' smart apparel for healthcare services, fitness, and motion capture.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Sports & Fitness

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

smart clothingwearable technologye-skinmotion captureECG monitoringremote patient monitoringmocap suitstretchable sensorssmart textilesEMS suitelectrical muscle stimulationEMSrehabilitation technologyambulatory ECGelderly monitoringfall detectioninertial motion capture

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xenoma Inc. Comparables

Compare Xenoma Inc. with similar companies based on industry and business-model similarity.

Xenoma Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Myant
85%
Mitsufuji Corporation
81%
Sensoria Fitness
81%

Xenoma Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingAug 10, 2022
Corporate FundingSep 11, 2020
Corporate FundingJun 1, 2020
Corporate FundingMay 15, 2018
SeedSep 27, 2017
Seed
Apr 1, 2016

Key People

Founding team and executive leadership

Yuka Tomitori

CFO

Executive Team

Xenoma Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors increased 33% MoM to 3.6K.

  • Jan 22, 2025

    Monthly visitors increased 85% MoM, reaching 2.4K.

Xenoma Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xenoma Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xenoma Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range8
Year Founded2015
Last FundingAug 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.